Skip to main content

NATIXIS ADVISORS, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1018331 Boston, MA

Position in ALNY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$22,670,870
-$3,142,283 QoQ
Shares Held
75,311
-3.5% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#120
of 780 holders
Holding Since
Jun 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NATIXIS ADVISORS, LLC holds $495,549,179 across 38 Biotechnology names. ALNY ranks #4 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 ALNY
Alnylam Pharmaceuticals, Inc.
This page
75,311 $22,670,870

All Filings in ALNY

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,670,870 75,311
2026-03-31 $25,813,153 78,016
2025-12-31 $17,629,812 44,335
2025-09-30 $9,886,992 21,682
2025-06-30 $3,296,443 10,109
2024-12-31 $2,459,695 10,453
2024-09-30 $2,750,850 10,002
2022-03-31 $1,691,521 10,359
2021-12-31 $2,123,650 12,523
2021-09-30 $3,748,256 19,852
2021-06-30 $1,931,002 11,391